Prudential Financial Inc Keros Therapeutics, Inc. Transaction History

Prudential Financial Inc

  • $70 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023
SELL
$41.44 - $59.32 $8,288 - $11,864
-200 Reduced 1.76%
11,172 $477,000
Q4 2022

Feb 14, 2023
BUY
$39.45 - $51.77 $5,325 - $6,988
135 Added 1.2%
11,372 $0
Q3 2022

Nov 04, 2022
BUY
$27.8 - $40.12 $312,388 - $450,828
11,237 New
11,237 $423,000

Others Institutions Holding KROS

# of Institutions
174
Shares Held
30.3M
Call Options Held
76.8K
Put Options Held
9K
View Full List

About Keros Therapeutics, Inc.

KROS Quotes by TradingView
  • Ticker KROS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,757,000
  • Market Cap $1.77B
  • Description
  • Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...
More about KROS
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email